Advertisements


Methenolone Acetate
Price: | US$ 100 |
---|---|
Minimum Order: | |
Payment Terms: | Bank transfer,Bitcoin,USDT, Dogecoin |
Port of Export: |
Product Details
Model No.: | Brand Name: |
---|
Certification: | |
---|---|
Specification: | g/kg |
Packaging & Delivery
Packaging: | |
---|---|
Delivery/Lead Time: | |
Production Capacity: |
Product Description
Methenolone Acetate powder is a short ester version of Methenolone, is a synthetic orally anabolic-androgenic steroid and a derivative of dihydrotestosterone (DHT). Initiately be sold under brand name”Primobolan & Nibal” for the treatment of anemia and muscles wasting, it is very similar in action to methenolone enanthate (primo e) powder, both produced by Aea.ltd. The only difference is methenolone acetate designed as oral administration and methenolone enanthate be adminised as injection version.Compared to 17 alpha- alkylated analogs, methenolone acetate have a higher therapeutic efficiency and lower hepatic toxicity. As a potent androgen, methenolone acetate binds to the androgen receptor and inhibit the production of gonadotropin hormones that regulate the synthesis of sex steroids, it has been marketed as a treatment for inoperable breast cancer and treat the wasting syndrome in HIV/AIDS patients.
As all known, methenolone acetate powder is a non-c17-alpha-alkylated oral steroid with low androgenic and no estrogenic properties, which is famous for its bodybuilding abilities , it is an excellent choice for men and women bodybuilders want to have a slow but steady muscle gain, methenolone acetate is beneficial to them maintain muscle gains when cutting or bulking, up to expecting results.
SUPPLIER PROFILE
|
|||
---|---|---|---|
Company: | Aea.ltd | ||
City/State | Hongkong, | Country: |
China ![]() |
Business Type: | Export/Import - Trading Company | Established: | NA |
Member Since: | 2024 | Contact Person | Vicky Liu |
SUPPLIER PROFILE
City/State/Country -
Hongkong,
China 

Business Type -
Export/Import - Trading Company
Established -
NA
Member Since -
2024
Contact Person -
Vicky Liu